Dutasteride and Agranulocytosis - a phase IV clinical study of FDA data

Summary:

Agranulocytosis is reported as a side effect among people who take Dutasteride (dutasteride), especially for people who are male, 60+ old, have been taking the drug for 1 - 6 months also take Tamsulosin, and have Systemic sclerosis (scleroderma).

The phase IV clinical study analyzes which people have Agranulocytosis when taking Dutasteride. It is created by eHealthMe based on reports of 8,125 people who have side effects when taking Dutasteride from the FDA, and is updated regularly.

What is Dutasteride?

Dutasteride has active ingredients of dutasteride. It is often used in prostate examination abnormal. eHealthMe is studying from 8,205 Dutasteride users. Check the latest studies of Dutasteride.

What is Agranulocytosis?

Agranulocytosis (a deficiency of granulocytes in the blood, causing increased vulnerability to infection) is found to be associated with 2,321 drugs and 3,597 conditions by eHealthMe. Check the latest studies of Agranulocytosis.

eHealthMe: drug outcomes in the real world

eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.

On Sep, 02, 2026

8,125 people reported to have side effects when taking Dutasteride.
Among them, 42 people (0.52%) have Agranulocytosis.

Could Dutasteride cause Agranulocytosis?

Among these 42 people:

How long have people been on Dutasteride when they have Agranulocytosis? *

What is the gender of people who have Agranulocytosis when taking Dutasteride? *

female: 0.0 %
male: 100 %

What is the age of people who have Agranulocytosis when taking Dutasteride? *

What are other drugs people take besides Dutasteride? *

Tamsulosin: 13 people, 30.95%
Amlodipine: 12 people, 28.57%
Cyclophosphamide: 11 people, 26.19%
Ramipril: 11 people, 26.19%
Bactrim: 10 people, 23.81%
Lansoprazole: 10 people, 23.81%
Calciparine: 9 people, 21.43%
Cellcept: 9 people, 21.43%
Furosemide: 9 people, 21.43%
Tamsulosin Hydrochloride: 8 people, 19.05%

What are other side effects people have besides Agranulocytosis? *

Thrombocytopenia (decrease of platelets in blood): 11 people, 26.19%
Diarrhea: 5 people, 11.90%
Leukopenia (less number of white blood cells in blood): 4 people, 9.52%
Skin Reaction: 3 people, 7.14%
Fever: 3 people, 7.14%
Stomatitis (inflammation of mucous membrane of mouth): 3 people, 7.14%
Weakness: 2 people, 4.76%
Pancytopenia (medical condition in which there is a reduction in the number of red and white blood cells, as well as platelets): 2 people, 4.76%
Pain: 2 people, 4.76%
Dry Eyes (lack of adequate tears): 2 people, 4.76%

What are the existing conditions these people have? *

High Blood Pressure: 9 people, 21.43%
Systemic Sclerosis (Scleroderma) (an autoimmune or connective tissue disease. it is characterized by thickening of the skin): 9 people, 21.43%
Atrial Fibrillation/flutter (atrial fibrillation and flutter are abnormal heart rhythms in which the atria, or upper chambers of the heart, are out of sync with the ventricles): 4 people, 9.52%
Brain Abscess: 4 people, 9.52%
Hyperuricaemia (level of uric acid in the blood that is abnormally high): 4 people, 9.52%
Anal Cancer: 3 people, 7.14%
Diabetes: 3 people, 7.14%
Lung Cancer - Non-Small Cell (lung cancer): 3 people, 7.14%
Depression: 3 people, 7.14%
Multiple Myeloma (cancer of the plasma cells): 3 people, 7.14%

* Approximation only. Some reports may have incomplete information.

Do you take Dutasteride and have Agranulocytosis?

- Check whether Agranulocytosis is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Dutasteride:

Dutasteride (8,205 reports)

Agranulocytosis treatments and more:

Agranulocytosis (213,267 reports)

Browse all side effects of Dutasteride:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Agranulocytosis:

Agranulocytosis (2,321 drugs)

Browse all the conditions that are associated with Agranulocytosis:

Agranulocytosis (3,597 conditions)

Related publications that referenced our studies

Fasullo, S., Davì, S., Cosenza, G., Di Franco, F., La Manna, N., Giubilato, A., ... & Maringhini, G. , "Acute agranulocytosis after oral administration of dabigatran: a rare case report and a short review of literature", Journal of thrombosis and thrombolysis, 2018 Jan .
Fasullo, S., Davì, S., Cosenza, G., Di Franco, F., La Manna, N., Giubilato, A., ... & Maringhini, G. , "Acute agranulocytosis after oral administration of dabigatran: a rare case report and a short review of literature", Journal of thrombosis and thrombolysis, 2018 Jan .

How the study uses the data?

The study uses data from the FDA. It is based on dutasteride (the active ingredients of Dutasteride) and Dutasteride (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.